Checkpoint Capital L.P.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1977548
SAN FRANCISCO, CA
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,461,153
-$9,367,847 QoQ
Shares Held
40,230
-84.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Checkpoint Capital L.P. holds $278,650,517 across 8 Biotechnology names. CRNX ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
153,000 | $111,728,250 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,227,200 | $106,729,584 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
262,539 | $25,531,917 | |
| 4 | IRON |
Disc Medicine, Inc.
|
286,661 | $18,329,104 | |
| 5 | CYTK |
Cytokinetics Inc
|
180,000 | $11,863,800 | |
| 6 | SEPN |
Septerna, Inc.
|
100,300 | $2,410,209 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
40,230 | $1,461,153 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
50,000 | $596,500 |
All Filings in CRNX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,461,153 | 40,230 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $10,829,000 | 260,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||